Talk Back: CT scans, mammograms, Avastin, Provenge: Who pays?

Widespread screening with CT scans can detect lung cancer. Regular mammograms of all women 40 and older can find breast cancer. Avastin, at $8,000 a month, has helped some patients with advanced breast cancer. And the prostate cancer drug Provenge, at $93,000 per patient, can extend survival by about four months.

Such were the headlines this week. But this made headlines too: Healthcare spending in the U.S. outpaces all other industrialized countries, amounting to 17.5% of our economic output. And we don’t have the life expectancy to show for it. The question currently being asked is: At what point can we -- should we -- say: “Enough”?

But for most people, the honest answer depends on two things: 1) whether they or a stranger have the condition and 2) who’s footing the bill. So … who should foot the bill?

Tell us what you think below.